SEO URLwww.firestrike.ai/deals/vivasure-haemonetics-acquisition-2026
acquisitionAnnounced · Jan 12, 2026Medical TechnologySource · MagazineArticle · Factual
Haemonetics acquires Vivasure
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
$215M
Target
Vivasure
Acquirer
Haemonetics
Full Acquisition
Status
Completed
Haemonetics agreed to acquire Vivasure. Reported deal value: $215M. Status: Completed. Sector: Medical Technology. Target headquarters context: Location not specified.
This page summarizes publicly available information about the transaction as of 2026-01-12. Figures and status may change as filings and press coverage update.
Haemonetics has acquired Vivasure , an Ireland - based company developing next-generation technology for percutaneous vessel closure, in a deal worth up to €185m upon completion of certain milestones
Deal timeline
Announced
Jan 12, 2026 · medicaldevice-network.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Medical Technology with a reported deal value of $215M. Figures and status may change as sources update.
Sources: medicaldevice-network.com · Primary article · FireStrike proprietary index